Company intelligence / Profile preview
Novaken
Guangzhou, Guangdong, China
- Ownership
- Private
- Employees
- ~100
- Development stage
- Other
01
Overview
Novaken has achieved two drug clinical trial approvals, several drug candidates in Phase 1 and preclinical, and over 10 patents for core technologies
- Therapeutic areas
- OncologyNeurology
- Modalities
- Small moleculeChemical drugsDrug sustained controlled release technologyGel release formulationsMicrosphere formulationMicroneedle formulationsPulmonary drug delivery
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Collaborations with Sun Yat-sen University, Jinan UniversityPartnerships with Zhuhai United Laboratories, KingYork Group, Guangzhou Baiyunshan Pharmaceutical Holdings, Humanwell Healthcare Group, China Resources Sanjiu, Chinese Medicines (Guangzhou) Co.
Beyond the preview
Go deeper on Novaken.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Novaken.